Multiplexed Analysis

Traditional immunoassays used typically in clinical diagnostics lack the ability to multiplex more than a handful of targets  at a time. The Ohmx platform offers the benefit of detecting multiple biomarkers and clinical analytes simultaneously in a sample (<10uL) without adding any additional labeling reagents or separating components. 

The detection and analysis is performed electronically without expensive and delicate optical components.  In many aspects the system can be compared to today's inexpensive blood glucose meters, where Ohmx's platform extends the range of analytes to include most clinically important biomarkers and indicators. Ohmx has proprietary technology to carry out the bioelectronic  detection of biomarkers on a single biochip.

[ back to top ]